GO:0001632 leukotriene B4 receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0001632 (leukotriene B4 receptor activity) is a molecular function defined as binding to leukotriene B4 (LTB4) to initiate a change in cell activity.
• The primary receptors are BLT1 (LTB4R) and BLT2 (LTB4R2), which are G-protein-coupled receptors that mediate LTB4 signaling.
• BLT1 activation by LTB4 involves a distinct binding pocket and conformational changes that couple to G proteins, as revealed by cryo-EM structures.
• LTB4 receptor activity is implicated in inflammatory diseases, allergic enteritis, non-alcoholic fatty liver disease (NAFLD), liver tumorigenesis, and cancers such as colorectal and renal cell carcinoma.
• BLT1 can also be activated by E-series resolvins (RvE1 and RvE2), suggesting broader ligand specificity.
• Studying this function requires tools like knockout mice, point mutations, and CRISPR screens to dissect receptor-specific signaling in disease models.
Description
Leukotriene B4 receptor activity (GO:0001632) is a molecular function that mediates cellular responses to the lipid mediator leukotriene B4 (LTB4). This function is essential for inflammatory signaling and has been linked to a variety of physiological and pathological processes. The receptors responsible, BLT1 and BLT2, are G-protein-coupled receptors (GPCRs) that, upon binding LTB4, trigger intracellular signaling cascades. Understanding this activity is critical for researchers studying inflammation, immune cell recruitment, and related diseases. Recent structural and functional studies have provided detailed insights into how LTB4 binds and activates its receptors, offering potential targets for therapeutic intervention.
leukotriene B4 receptor activity At A Glance
| GO ID | GO:0001632 |
|---|---|
| GO term | leukotriene B4 receptor activity |
| Ontology | molecular_function |
| Synonym | BLT receptor |
| Definition | Combining with leukotriene B4, LTB4, to initiate a change in cell activity. |
| Major function | Mediates cellular responses to LTB4, including chemotaxis and inflammatory signaling. |
| Receptor subtypes | BLT1 (LTB4R) and BLT2 (LTB4R2). |
| Ligand | Leukotriene B4 (LTB4), also known as (6Z, 8E, 10E, 14Z)-(5S, 12R)-5,12-dihydroxyicosa-6,8,10,14-tetraen-1-oate. |
| Signaling pathway | G-protein-coupled receptor signaling, often via Gi/o and Gq proteins. |
What Is GO:0001632?
Leukotriene B4 receptor activity (GO:0001632) is defined as the function of combining with leukotriene B4 (LTB4) to initiate a change in cell activity. LTB4 is a potent lipid chemoattractant involved in inflammatory responses. This activity is mediated by specific cell surface receptors, primarily BLT1 and BLT2, which belong to the G-protein-coupled receptor family.
Why Is leukotriene B4 receptor activity Important in Cell Biology?
Leukotriene B4 receptor activity is a key driver of inflammatory responses and has been implicated in numerous diseases, including allergic enteritis, NAFLD, liver cancer, and colorectal cancer. The receptors BLT1 and BLT2 are attractive targets for anti-inflammatory therapies, and understanding their activation mechanisms can guide drug development. Moreover, the role of these receptors in cancer progression and immune infiltration highlights their potential as prognostic biomarkers and therapeutic targets.
• Mediates chemotaxis and activation of immune cells in inflammation.
• BLT1 deficiency ameliorates allergic enteritis in mice, indicating a role in allergic inflammation.
• Hepatocyte BLT1 promotes NAFLD development in obesity, linking LTB4 signaling to metabolic liver disease.
• Hepatic stellate cell BLT2 activation promotes liver tumorigenesis, suggesting a role in hepatocellular carcinoma.
• BLT1 knockdown affects PI3K/AKT/mTOR signaling and apoptosis in colorectal cancer cells.
• BLT2 expression correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.
• LTB4 receptors are GPCRs, making them druggable targets for small molecule modulators.
• Structural insights into BLT1 activation enable rational design of receptor-specific therapeutics.
• E-series resolvins can activate BLT1, suggesting complex regulation of inflammatory resolution.
• CRISPR-based models (KO, point mutation, knock-in) are essential for dissecting receptor-specific functions in disease.
What Happens During leukotriene B4 receptor activity?
Ligand Binding and Receptor Activation
In simple terms: LTB4 binds to its receptor like a key in a lock, causing the receptor to change shape and send signals inside the cell.
Leukotriene B4 (LTB4) binds to the extracellular pocket of BLT1 (LTB4R) and BLT2 (LTB4R2), inducing conformational changes that activate the receptor. Structural studies of BLT1 have revealed that LTB4 occupies a distinct binding site, and its interaction triggers rearrangements in transmembrane helices that are critical for G-protein coupling. Molecular dynamics simulations have further detailed the activation process and the binding of alternative ligands such as E-series resolvins.
G-Protein Coupling and Signal Transduction
In simple terms: Once activated, the receptor interacts with G proteins inside the cell, which then relay the signal to downstream effectors.
Activated BLT1 and BLT2 couple to heterotrimeric G proteins, primarily Gi/o and Gq, leading to the inhibition of adenylyl cyclase, activation of phospholipase C, and mobilization of intracellular calcium. This signaling cascade results in cellular responses such as chemotaxis, adhesion, and cytokine production. The specific G-protein subtypes involved can vary by cell type and context.
Downstream Effector Pathways
In simple terms: The signal from the receptor triggers multiple pathways inside the cell, including those that control cell growth, survival, and movement.
LTB4 receptor activation leads to the activation of PI3K/AKT/mTOR signaling, which regulates cell survival, proliferation, and apoptosis. In colorectal cancer cells, BLT1 knockdown affects these pathways, suggesting a direct link between receptor activity and oncogenic signaling. Additionally, BLT2 activation in hepatic stellate cells promotes β-catenin signaling, contributing to liver tumorigenesis.
Receptor Regulation and Desensitization
In simple terms: After signaling, the receptor can be turned off or internalized to prevent excessive responses.
Like many GPCRs, LTB4 receptors undergo desensitization and internalization following prolonged agonist exposure, a process mediated by phosphorylation and arrestin recruitment. This regulation is crucial for terminating inflammatory signals and preventing chronic inflammation. However, the precise mechanisms for BLT1 and BLT2 may differ and are an active area of research.
Key Genes Involved in GO:0001632 leukotriene B4 receptor activity
The following genes encode receptors and signaling components directly involved in leukotriene B4 receptor activity.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LTB4R (BLT1) | High-affinity receptor for LTB4; mediates chemotaxis and inflammatory signaling | Target for anti-inflammatory drugs; implicated in allergic enteritis, NAFLD, and colorectal cancer |
| LTB4R2 (BLT2) | Low-affinity receptor for LTB4; also binds other eicosanoids | Promotes liver tumorigenesis and correlates with prognosis in renal cell carcinoma |
| GNAI1 | Gi/o alpha subunit; inhibits adenylyl cyclase upon receptor activation | Mediates LTB4-induced signaling in immune cells |
| GNAQ | Gq alpha subunit; activates phospholipase C | Contributes to calcium mobilization and inflammatory responses |
| PIK3CA | Catalytic subunit of PI3K; activated downstream of BLT1 | Links LTB4 signaling to AKT/mTOR pathway in cancer |
| AKT1 | Serine/threonine kinase; promotes cell survival and proliferation | Effector of PI3K pathway activated by LTB4 receptors |
| MTOR | Kinase; regulates protein synthesis and cell growth | Downstream of AKT; modulated by BLT1 in colorectal cancer |
| CTNNB1 | β-catenin; transcription factor in Wnt signaling | Activated by BLT2 in hepatic stellate cells to promote tumorigenesis |
| ALOX5 | 5-lipoxygenase; synthesizes LTB4 from arachidonic acid | Upstream of receptor activation; target for anti-inflammatory drugs |
| ALOX5AP | 5-lipoxygenase-activating protein; required for LTB4 synthesis | Essential for ligand production |
| LTA4H | Leukotriene A4 hydrolase; converts LTA4 to LTB4 | Final step in LTB4 biosynthesis |
| PLA2G4A | Cytosolic phospholipase A2; releases arachidonic acid | Initiates LTB4 synthesis pathway |
| ARRB1 | β-arrestin 1; mediates receptor desensitization and internalization | Regulates LTB4 receptor signaling |
| ARRB2 | β-arrestin 2; mediates receptor desensitization and internalization | Regulates LTB4 receptor signaling |
| GRK2 | G-protein-coupled receptor kinase 2; phosphorylates activated receptors | Promotes desensitization of BLT1 |
| GRK5 | G-protein-coupled receptor kinase 5; phosphorylates activated receptors | May regulate BLT1 desensitization |
| PRKACA | Protein kinase A; downstream of cAMP inhibition | Modulates inflammatory gene expression |
| PRKCA | Protein kinase C; activated by DAG and calcium | Mediates downstream effects of BLT1 signaling |
How Is leukotriene B4 receptor activity Regulated?
Leukotriene B4 receptor activity is regulated at multiple levels. Receptor desensitization and internalization are controlled by G-protein-coupled receptor kinases (GRKs) and β-arrestins. The availability of the ligand LTB4 is regulated by enzymes in the arachidonic acid cascade, including PLA2G4A, ALOX5, ALOX5AP, and LTA4H. Additionally, downstream signaling pathways such as PI3K/AKT/mTOR can feedback to modulate receptor activity and expression. In disease contexts, receptor expression levels can be altered, as seen in colorectal cancer and renal cell carcinoma.
leukotriene B4 receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LTB4R (BLT1) | Allergic enteritis | Knockout mice in ovalbumin-induced model |
| LTB4R (BLT1) | NAFLD | Hepatocyte-specific knockout mice on high-fat diet |
| LTB4R2 (BLT2) | Liver tumorigenesis | Hepatic stellate cell-specific knockout or overexpression in mice |
| LTB4R (BLT1) | Colorectal cancer | CRISPR knockout in HCT116 or SW480 cell lines |
| LTB4R2 (BLT2) | Clear cell renal cell carcinoma | Knockdown or overexpression in 786-O or ACHN cells |
Inflammatory and Allergic Diseases
LTB4 receptor activity is a key mediator of inflammation. BLT1 deficiency ameliorates ovalbumin-induced allergic enteritis in mice, demonstrating its role in allergic inflammation. The receptor promotes chemotaxis and activation of neutrophils and eosinophils, contributing to tissue damage in inflammatory conditions.
Metabolic Liver Disease and Cancer
Hepatocyte BLT1 promotes non-alcoholic fatty liver disease (NAFLD) development in obesity, linking LTB4 signaling to metabolic dysfunction. In hepatic stellate cells, BLT2 activation of β-catenin drives liver tumorigenesis, suggesting a role in hepatocellular carcinoma. These findings highlight the receptor's involvement in liver pathology.
Colorectal Cancer
BLT1 knockdown in colorectal cancer cells affects PI3K/AKT/mTOR signaling and apoptotic responses, indicating that LTB4 receptor activity promotes tumor cell survival and proliferation. Targeting this pathway may offer therapeutic benefits in colorectal cancer.
Renal Cell Carcinoma
BLT2 expression correlates with prognosis and immune infiltration in clear cell renal cell carcinoma, suggesting that LTB4 receptor activity influences tumor progression and the immune microenvironment. This receptor may serve as a prognostic biomarker and therapeutic target.
From leukotriene B4 receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does BLT1 mediate allergic enteritis? | BLT1 knockout mice in ovalbumin-induced model |
| What is the role of hepatocyte BLT1 in NAFLD? | Hepatocyte-specific BLT1 knockout mice fed high-fat diet |
| How does BLT2 in hepatic stellate cells promote tumorigenesis? | Stellate cell-specific BLT2 knockout or overexpression in liver cancer models |
| Does BLT1 knockdown affect PI3K/AKT/mTOR in colorectal cancer? | CRISPR knockout of LTB4R in colorectal cancer cell lines |
| Is BLT2 a prognostic marker in renal cell carcinoma? | Knockdown or overexpression in renal cancer cell lines and xenografts |
| What is the structural basis of BLT1 activation? | Cryo-EM structures of BLT1 in complex with LTB4 and G proteins |
How to Study the leukotriene B4 receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of receptor-ligand-G protein complex | Determining activation mechanism of BLT1 |
| Molecular dynamics simulation | Ligand binding and conformational changes | Modeling BLT1 activation by LTB4 and resolvins |
| CRISPR knockout | Loss-of-function effects on signaling and phenotype | Studying BLT1 in colorectal cancer cells |
| Knockout mouse models | In vivo role of receptor in disease | Allergic enteritis and NAFLD studies |
| Calcium mobilization assay | Gq-mediated signaling | Measuring receptor activation by LTB4 |
| cAMP inhibition assay | Gi-mediated signaling | Assessing receptor coupling to Gi |
| Western blotting | Phosphorylation of downstream effectors | PI3K/AKT/mTOR pathway analysis |
| Immunohistochemistry | Receptor expression and localization | Correlating BLT2 with prognosis in renal cancer |
Structural Biology (Cryo-EM and Molecular Dynamics)
Cryo-electron microscopy has been used to solve the structure of BLT1 bound to LTB4, revealing the ligand binding pocket and conformational changes required for G-protein coupling. Molecular dynamics simulations complement these studies by modeling the activation process and ligand interactions, including with E-series resolvins.
CRISPR-Based Genetic Screens
CRISPR knockout screens can identify genes that modulate LTB4 receptor signaling or are synthetic lethal with receptor activation. For example, knocking out LTB4R in cancer cell lines followed by pathway analysis has revealed effects on PI3K/AKT/mTOR signaling. Such screens are powerful for discovering novel regulators of this function.
Animal Models and Disease Phenotyping
Knockout mouse models have been instrumental in linking LTB4 receptor activity to diseases. BLT1-deficient mice show reduced allergic enteritis, and hepatocyte-specific BLT1 knockout protects against NAFLD. These models allow researchers to study the physiological consequences of receptor loss in vivo.
Cell Signaling Assays
Standard assays for GPCR activity, such as calcium mobilization, cAMP inhibition, and β-arrestin recruitment, are used to measure LTB4 receptor activation. Downstream pathways like PI3K/AKT/mTOR can be assessed by Western blotting for phosphorylated proteins. These methods are essential for validating receptor function and testing inhibitors.
How CRISPR Can Be Used to Study GO:0001632 leukotriene B4 receptor activity
Knockout
CRISPR knockout of LTB4R or LTB4R2 is used to eliminate receptor activity and study its loss-of-function effects. For example, BLT1 knockdown in colorectal cancer cells affects PI3K/AKT/mTOR signaling and apoptosis. Knockout mice for BLT1 have been generated to study allergic enteritis and NAFLD.
Point Mutation
Point mutations can be introduced into LTB4R to dissect the contribution of specific residues to ligand binding or G-protein coupling. Such mutations help validate structural findings and identify key determinants of receptor activation.
Knock-in
Knock-in of tagged or fluorescently labeled receptors allows real-time tracking of receptor localization and trafficking. This approach can be used to study receptor internalization and desensitization in live cells.
Overexpression
Overexpression of BLT1 or BLT2 in cell lines is used to amplify receptor signaling and study downstream effects. For instance, BLT2 overexpression in hepatic stellate cells promotes β-catenin signaling and tumorigenesis. Overexpression models are valuable for gain-of-function studies.
How EDITGENE Supports leukotriene B4 receptor activity Research
Researchers studying leukotriene B4 receptor activity-related genes often need to determine whether a candidate gene is causally involved in receptor signaling, inflammation, or cancer progression. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for leukotriene B4 receptor activity research.
Frequently Asked Questions About leukotriene B4 receptor activity
What is leukotriene B4 receptor activity?
Leukotriene B4 receptor activity (GO:0001632) is a molecular function where a receptor binds leukotriene B4 (LTB4) to initiate a change in cell activity, typically through G-protein-coupled signaling.
What genes are involved in leukotriene B4 receptor activity?
The primary genes are LTB4R (BLT1) and LTB4R2 (BLT2), which encode the receptors. Downstream signaling involves G proteins (GNAI1, GNAQ), PI3K/AKT/mTOR pathway components, and β-catenin.
What diseases are associated with leukotriene B4 receptor activity?
It is implicated in allergic enteritis, non-alcoholic fatty liver disease (NAFLD), liver tumorigenesis, colorectal cancer, and clear cell renal cell carcinoma.
How is leukotriene B4 receptor activity regulated?
It is regulated by receptor desensitization via GRKs and β-arrestins, ligand availability through the arachidonic acid cascade, and feedback from downstream pathways like PI3K/AKT/mTOR.
What is the structure of the leukotriene B4 receptor?
BLT1 is a G-protein-coupled receptor with seven transmembrane helices. Cryo-EM structures have revealed the LTB4 binding pocket and conformational changes upon activation.
Can leukotriene B4 receptors be targeted for therapy?
Yes, BLT1 and BLT2 are considered druggable targets for anti-inflammatory and anti-cancer therapies. Structural insights aid rational drug design.
What are BLT1 and BLT2?
BLT1 (LTB4R) is a high-affinity receptor for LTB4, while BLT2 (LTB4R2) is a low-affinity receptor that also binds other eicosanoids. Both mediate LTB4 signaling.
How do researchers study leukotriene B4 receptor activity?
Common methods include CRISPR knockout, animal models, cryo-EM, molecular dynamics, calcium mobilization assays, and Western blotting for downstream signaling.
What is the role of BLT1 in cancer?
BLT1 promotes cancer cell survival and proliferation via PI3K/AKT/mTOR signaling. Knockdown in colorectal cancer cells reduces these pathways and increases apoptosis.
What is the role of BLT2 in liver disease?
BLT2 activation in hepatic stellate cells promotes β-catenin signaling and liver tumorigenesis, suggesting a role in hepatocellular carcinoma.
Conclusion
Leukotriene B4 receptor activity (GO:0001632) is a critical molecular function that mediates inflammatory and oncogenic signaling through the receptors BLT1 and BLT2. Structural and functional studies have elucidated the activation mechanism, and disease models have linked this activity to allergic enteritis, NAFLD, liver cancer, colorectal cancer, and renal cell carcinoma. Targeting these receptors holds therapeutic promise, and continued research using CRISPR and other advanced tools will further unravel their biology.
References
- 1. Wang N et al.. 2022. Structural basis of leukotriene B4 receptor 1 activation.. Nat Commun 13(1):1156 PMID: 35241677
- 2. Nunes VS et al.. 2024. Leukotriene B4 receptor 1 (BLT1) activation by leukotriene B4 (LTB(4)) and E resolvins (RvE1 and RvE2).. Comput Biol Chem 113:108236 PMID: 39395248
- 3. Kato S et al.. 2023. Deficiency of leukotriene B4 receptor type 1 ameliorates ovalbumin-induced allergic enteritis in mice.. Clin Exp Pharmacol Physiol 50(9):766-775 PMID: 37406678
- 4. Liu X et al.. 2023. Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity.. Hepatology 78(2):562-577 PMID: 35931467
- 5. Sinha S et al.. 2023. Hepatic stellate cell stearoyl co-A desaturase activates leukotriene B4 receptor 2 - β-catenin cascade to promote liver tumorigenesis.. Nat Commun 14(1):2651 PMID: 37156770
- 6. Tang C et al.. 2024. Leukotriene B4 receptor knockdown affects PI3K/AKT/mTOR signaling and apoptotic responses in colorectal cancer.. Biomol Biomed 24(4):968-981 PMID: 38259082
- 7. Yuan X et al.. 2022. Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.. Invest New Drugs 40(2):232-244 PMID: 34633577
- 8. Toda A et al.. 2002. Leukotriene B4 receptors.. Prostaglandins Other Lipid Mediat 68-69:575-85 PMID: 12432944
